Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Trial of Zolpidem for Sleep in Children With Autism [Phase 2]

View source ↗

Summary

Stanford University is conducting a Phase 2 trial to evaluate zolpidem as a sleep aid for children with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem (zolpidem)

Snippet

Sponsor: Stanford University | Conditions: Autism, Autism Spectrum Disorder | Phase 2 | Status: RECRUITING